BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18990233)

  • 1. Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma.
    Sinha S; Singh RK; Alam N; Roy A; Roychoudhury S; Panda CK
    Mol Cancer; 2008 Nov; 7():84. PubMed ID: 18990233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of FANCC and PTCH1 with the development of early dysplastic lesions of the head and neck.
    Ghosh A; Ghosh S; Maiti GP; Mukherjee S; Mukherjee N; Chakraborty J; Roy A; Roychoudhury S; Panda CK
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S528-38. PubMed ID: 21861228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of 9q22.3 tumor suppressor genes predict outcome for patients with head and neck squamous cell carcinoma.
    Ghosh A; Maiti GP; Bandopadhyay MN; Chakraborty J; Biswas J; Roychoudhury S; Panda CK
    Anticancer Res; 2013 Mar; 33(3):1215-20. PubMed ID: 23482805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent alterations of hMLH1 and RBSP3/HYA22 at chromosomal 3p22.3 region in early and late-onset breast carcinoma: clinical and prognostic significance.
    Sinha S; Singh RK; Alam N; Roy A; Roychoudhury S; Panda CK
    Cancer Sci; 2008 Oct; 99(10):1984-91. PubMed ID: 19016758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of different deleted regions in chromosome 11 and their interrelations in early- and late-onset breast tumors: association with cyclin D1 amplification and survival.
    Chunder N; Mandal S; Roy A; Roychoudhury S; Panda CK
    Diagn Mol Pathol; 2004 Sep; 13(3):172-82. PubMed ID: 15322430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of the human homologue of Drosophila patched and the xeroderma pigmentosum complementation group A genes in squamous cell carcinomas of the skin.
    Eklund LK; Lindström E; Undén AB; Lundh-Rozell B; Ståhle-Bäckdahl M; Zaphiropoulos PG; Toftgård R; Söderkvist P
    Mol Carcinog; 1998 Feb; 21(2):87-92. PubMed ID: 9496908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the multiple self-healing squamous epithelioma (MSSE) gene and investigation of xeroderma pigmentosum group A (XPA) and PATCHED (PTCH) as candidate genes.
    Richards FM; Goudie DR; Cooper WN; Jene Q; Barroso I; Wicking C; Wainwright BJ; Ferguson-Smith MA
    Hum Genet; 1997 Dec; 101(3):317-22. PubMed ID: 9439661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple tumor types including leiomyoma and Wilms tumor in a patient with Gorlin syndrome due to 9q22.3 microdeletion encompassing the PTCH1 and FANC-C loci.
    Garavelli L; Piemontese MR; Cavazza A; Rosato S; Wischmeijer A; Gelmini C; Albertini E; Albertini G; Forzano F; Franchi F; Carella M; Zelante L; Superti-Furga A
    Am J Med Genet A; 2013 Nov; 161A(11):2894-901. PubMed ID: 24124115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microdeletion of 9q22.3: A patient with minimal deletion size associated with a severe phenotype.
    Ewing AD; Cheetham SW; McGill JJ; Sharkey M; Walker R; West JA; West MJ; Summers KM
    Am J Med Genet A; 2021 Jul; 185(7):2070-2083. PubMed ID: 33960642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of PTCH1 is associated with the development of cervical carcinoma: clinical and prognostic implication.
    Chakraborty C; Dutta S; Mukherjee N; Samadder S; Roychowdhury A; Roy A; Mondal RK; Basu P; Roychoudhury S; Panda CK
    Tumour Biol; 2015 Feb; 36(2):1143-54. PubMed ID: 25330948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation of the PTCH1 gene promoter region in aberrant crypt foci.
    Peng L; Hu J; Li S; Wang Z; Xia B; Jiang B; Li B; Zhang Y; Wang J; Wang X
    Int J Cancer; 2013 Jan; 132(2):E18-25. PubMed ID: 22945423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two truncating variants in FANCC and breast cancer risk.
    Dörk T; Peterlongo P; Mannermaa A; Bolla MK; Wang Q; Dennis J; Ahearn T; Andrulis IL; Anton-Culver H; Arndt V; Aronson KJ; Augustinsson A; Freeman LEB; Beckmann MW; Beeghly-Fadiel A; Behrens S; Bermisheva M; Blomqvist C; Bogdanova NV; Bojesen SE; Brauch H; Brenner H; Burwinkel B; Canzian F; Chan TL; Chang-Claude J; Chanock SJ; Choi JY; Christiansen H; Clarke CL; Couch FJ; Czene K; Daly MB; Dos-Santos-Silva I; Dwek M; Eccles DM; Ekici AB; Eriksson M; Evans DG; Fasching PA; Figueroa J; Flyger H; Fritschi L; Gabrielson M; Gago-Dominguez M; Gao C; Gapstur SM; García-Closas M; García-Sáenz JA; Gaudet MM; Giles GG; Goldberg MS; Goldgar DE; Guénel P; Haeberle L; Haiman CA; Håkansson N; Hall P; Hamann U; Hartman M; Hauke J; Hein A; Hillemanns P; Hogervorst FBL; Hooning MJ; Hopper JL; Howell T; Huo D; Ito H; Iwasaki M; Jakubowska A; Janni W; John EM; Jung A; Kaaks R; Kang D; Kapoor PM; Khusnutdinova E; Kim SW; Kitahara CM; Koutros S; Kraft P; Kristensen VN; Kwong A; Lambrechts D; Marchand LL; Li J; Lindström S; Linet M; Lo WY; Long J; Lophatananon A; Lubiński J; Manoochehri M; Manoukian S; Margolin S; Martinez E; Matsuo K; Mavroudis D; Meindl A; Menon U; Milne RL; Mohd Taib NA; Muir K; Mulligan AM; Neuhausen SL; Nevanlinna H; Neven P; Newman WG; Offit K; Olopade OI; Olshan AF; Olson JE; Olsson H; Park SK; Park-Simon TW; Peto J; Plaseska-Karanfilska D; Pohl-Rescigno E; Presneau N; Rack B; Radice P; Rashid MU; Rennert G; Rennert HS; Romero A; Ruebner M; Saloustros E; Schmidt MK; Schmutzler RK; Schneider MO; Schoemaker MJ; Scott C; Shen CY; Shu XO; Simard J; Slager S; Smichkoska S; Southey MC; Spinelli JJ; Stone J; Surowy H; Swerdlow AJ; Tamimi RM; Tapper WJ; Teo SH; Terry MB; Toland AE; Tollenaar RAEM; Torres D; Torres-Mejía G; Troester MA; Truong T; Tsugane S; Untch M; Vachon CM; Ouweland AMWVD; Veen EMV; Vijai J; Wendt C; Wolk A; Yu JC; Zheng W; Ziogas A; Ziv E; ; ; Dunning AM; Pharoah PDP; Schindler D; Devilee P; Easton DF
    Sci Rep; 2019 Aug; 9(1):12524. PubMed ID: 31467304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.
    Thompson ER; Doyle MA; Ryland GL; Rowley SM; Choong DY; Tothill RW; Thorne H; ; Barnes DR; Li J; Ellul J; Philip GK; Antill YC; James PA; Trainer AH; Mitchell G; Campbell IG
    PLoS Genet; 2012 Sep; 8(9):e1002894. PubMed ID: 23028338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential association of BRCA1 and BRCA2 genes with some breast cancer-associated genes in early and late onset breast tumors.
    Chunder N; Mandal S; Roy A; Roychoudhury S; Panda CK
    Ann Surg Oncol; 2004 Dec; 11(12):1045-55. PubMed ID: 15576832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer.
    Wolf I; Bose S; Desmond JC; Lin BT; Williamson EA; Karlan BY; Koeffler HP
    Breast Cancer Res Treat; 2007 Oct; 105(2):139-55. PubMed ID: 17295047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications.
    Sinha S; Singh RK; Bhattacharya N; Mukherjee N; Ghosh S; Alam N; Roy A; Roychoudhury S; Panda CK
    Mol Oncol; 2011 Oct; 5(5):454-64. PubMed ID: 21803008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas.
    Bisogna M; Calvano JE; Ho GH; Orlow I; Cordón-Cardó C; Borgen PI; Van Zee KJ
    Cancer Genet Cytogenet; 2001 Mar; 125(2):131-8. PubMed ID: 11369056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in the human xeroderma pigmentosum group A gene and their impact on cell survival and nucleotide excision repair.
    Mellon I; Hock T; Reid R; Porter PC; States JC
    DNA Repair (Amst); 2002 Jul; 1(7):531-46. PubMed ID: 12509227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The patched polymorphism Pro1315Leu (C3944T) may modulate the association between use of oral contraceptives and breast cancer risk.
    Chang-Claude J; Dunning A; Schnitzbauer U; Galmbacher P; Tee L; Wjst M; Chalmers J; Zemzoum I; Harbeck N; Pharoah PD; Hahn H
    Int J Cancer; 2003 Mar; 103(6):779-83. PubMed ID: 12516098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Functional Polymorphism (rs10817938) in the XPA Promoter Region Is Associated with Poor Prognosis of Oral Squamous Cell Carcinoma in a Chinese Han Population.
    Gao C; Wang J; Li C; Zhang W; Liu G
    PLoS One; 2016; 11(9):e0160801. PubMed ID: 27622501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.